Comparison of pharmacokinetics and safety characteristics between two olopatadine hydrochloride 5 mg tablet formulations in healthy Korean subjects.
Jae Hoon KimMinyu LeeNamsick KimTae-Young OhSeung-Kwan NamYoon Seok ChoiIn Sun KwonJin Gyu JungJang-Hee HongPublished in: Translational and clinical pharmacology (2021)
Clinical Research Information Service Identifier: KCT0005943.